EIKN Eikon Therapeutics, Inc.

NASDAQ
$5.17

Eikon Therapeutics, Inc. (EIKN) is expected to report earnings on February 11, 2027, before the market open. The consensus earnings estimate is a loss of $1.78 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -23.8% since its last earnings release on November 12, 2026.

Eikon Therapeutics Beat Consensus Estimates
Thursday, November 12, 2026 · 6:30 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 11
Thursday · Before Open
Earnings Whisper
-
vs ($1.78)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $5.66

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.